UB Paderborn / Katalog / Suche / in CDI

1 – 22 von 22

Sortiert nach

Efficacy and safety of a liposome-based vaccine against protein Tau, assessed in tau.P301L mice that model tauopathy

PloS one, 2013-08, Vol.8 (8), p.e72301-e72301

2013

Link zum Volltext

Verfügbarkeit prüfen

Liposomal vaccines with conformation-specific amyloid peptide antigens define immune response and efficacy in APP transgenic mice

Proceedings of the National Academy of Sciences - PNAS, 2007-06, Vol.104 (23), p.9810-9815

2007

Link zum Volltext

Verfügbarkeit prüfen

DEVELOPMENT OF HIGHLY SENSITIVE MSD ASSAYS FOR THE DETECTION OF ANTI-AMYLOID β MONOMER- AND OLIGOMER-SPECIFIC ANTIBODIES IN HUMAN SERUM

Alzheimer's & dementia, 2017-07, Vol.13 (7), p.P957-P957

2017

Link zum Volltext

Verfügbarkeit prüfen

EFFICACY OF ACI-35, A LIPOSOMAL ANTI-PHOSPHO TAU VACCINE IN TWO DIFFERENT MOUSE MODELS OF ALZHEIMER’S DISEASE

Alzheimer's & dementia, 2016-07, Vol.12 (7), p.P260-P261

2016

Link zum Volltext

Verfügbarkeit prüfen

O2‐13‐03: Efficacy of ACI‐35, A Liposomal Anti‐Phospho Tau Vaccine in Two Different Mouse Models of Alzheimer's Disease

Alzheimer's & dementia, 2016-07, Vol.12 (7S_Part_5), p.P260-P261

2016

Link zum Volltext

Verfügbarkeit prüfen

Cloning and overexpression of the Lactobacillus bulgaricus NAD +-dependent D-lactate dehydrogenase gene in Escherichia coli: Purification and characterization of the recombinant enzyme

Biochemical and biophysical research communications, 1992-06, Vol.185 (2), p.705-712

1992

Link zum Volltext

Verfügbarkeit prüfen

A liposomal anti-phospho-tau vaccine demonstrates higher immunogenicity and specificity than a classical peptide vaccine approach

Alzheimer's & dementia, 2013-07, Vol.9 (4), p.P326-P326

2013

Link zum Volltext

Verfügbarkeit prüfen

O2–06–04: A liposomal anti‐phospho‐tau vaccine demonstrates higher immunogenicity and specificity than a classical peptide vaccine approach

Alzheimer's & dementia, 2013-07, Vol.9 (4S_Part_8), p.P326-P326

2013

Link zum Volltext

Verfügbarkeit prüfen

P2‐525: Novel phospho‐Tau specific monoclonal antibodies for the treatment of Tau‐mediated pathology

Alzheimer's & dementia, 2011-07, Vol.7 (4S_Part_14), p.S480-S480

2011

Link zum Volltext

Verfügbarkeit prüfen

P2‐387: Phospho‐tau–specific vaccine for the treatment of tau pathology

Alzheimer's & dementia, 2012-07, Vol.8 (4S_Part_11), p.P398-P399

2012

Link zum Volltext

Verfügbarkeit prüfen

Phospho-tau–specific vaccine for the treatment of tau pathology

Alzheimer's & dementia, 2012-07, Vol.8 (4), p.P398-P399

2012

Link zum Volltext

Verfügbarkeit prüfen

Novel phospho-tau-specific liposome-based vaccines to treat tau pathology

Alzheimer's & dementia, 2011-07, Vol.7 (4), p.S687-S687

2011

Link zum Volltext

Verfügbarkeit prüfen

O4‐03‐04: Novel phospho‐tau‐specific liposome‐based vaccines to treat tau pathology

Alzheimer's & dementia, 2011-07, Vol.7 (4S_Part_20), p.S687-S687

2011

Link zum Volltext

Verfügbarkeit prüfen

Novel phospho-Tau specific monoclonal antibodies for the treatment of Tau-mediated pathology

Alzheimer's & dementia, 2011-07, Vol.7 (4), p.S480-S480

2011

Link zum Volltext

Verfügbarkeit prüfen

P3‐281: The safety profile of ACI‐24, an oligo‐specific amyloid beta vaccine, demonstrated decrease of large microbleedings in brain of aged Alzheimer's disease mouse model

Alzheimer's & dementia, 2009-07, Vol.5 (4S_Part_14), p.P425-P426

2009

Link zum Volltext

Verfügbarkeit prüfen

The safety profile of ACI-24, an oligo-specific amyloid beta vaccine, demonstrated decrease of large microbleedings in brain of aged Alzheimer's disease mouse model

Alzheimer's & dementia, 2009-07, Vol.5 (4), p.P425-P426

2009

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety of A Liposome-Based Vaccine against Protein Tau, Assessed in Tau.P301L Mice That Model Tauopathy. e72301

PloS one, 2013-08, Vol.8 (8)

2013

Link zum Volltext

Verfügbarkeit prüfen

Cloning and overexpression of Lactobacillus helveticusd‐lactate dehydrogenase gene in Escherichia coli

European journal of biochemistry, 1992-09, Vol.208 (3), p.799-805

1992

Link zum Volltext

Verfügbarkeit prüfen

Glutamate 264 modulates the pH dependence of the NAD(+)-dependent D-lactate dehydrogenase

The Journal of biological chemistry, 1992-10, Vol.267 (28), p.20298-20301

1992

Link zum Volltext

Verfügbarkeit prüfen

Cloning and overexpression of Lactobacillus helveticus D-lactate dehydrogenase gene in Escherichia coli

European journal of biochemistry, 1992-09, Vol.208 (3), p.799-805

1992

Link zum Volltext

Verfügbarkeit prüfen

1 – 22 von 22

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(20)

Publikationsform

Artikel
(22)

Sprache

Englisch
(22)
Japanisch
(2)

Erscheinungsjahr

n.n

Zeitschrift / Serie

2 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Efficacy and safety of a liposome-based vaccine against protein Tau, assessed in tau.P301L mice that model tauopathy

Liposomal vaccines with conformation-specific amyloid peptide antigens define immune response and efficacy in APP transgenic mice

Optimized ACI‐24, an amyloid beta (Abeta) vaccine that safely drives immunity to oligomers and Pyroglutamate Abeta, key pathological species of Alzheimer’s disease (AD)

DEVELOPMENT OF HIGHLY SENSITIVE MSD ASSAYS FOR THE DETECTION OF ANTI-AMYLOID β MONOMER- AND OLIGOMER-SPECIFIC ANTIBODIES IN HUMAN SERUM

TLR4- and TRIF-dependent stimulation of B lymphocytes by peptide liposomes enables T cell–independent isotype switch in mice

EFFICACY OF ACI-35, A LIPOSOMAL ANTI-PHOSPHO TAU VACCINE IN TWO DIFFERENT MOUSE MODELS OF ALZHEIMER’S DISEASE

O2‐13‐03: Efficacy of ACI‐35, A Liposomal Anti‐Phospho Tau Vaccine in Two Different Mouse Models of Alzheimer's Disease

Cloning and overexpression of the Lactobacillus bulgaricus NAD +-dependent D-lactate dehydrogenase gene in Escherichia coli: Purification and characterization of the recombinant enzyme

A liposomal anti-phospho-tau vaccine demonstrates higher immunogenicity and specificity than a classical peptide vaccine approach

O2–06–04: A liposomal anti‐phospho‐tau vaccine demonstrates higher immunogenicity and specificity than a classical peptide vaccine approach

P2‐525: Novel phospho‐Tau specific monoclonal antibodies for the treatment of Tau‐mediated pathology

P2‐387: Phospho‐tau–specific vaccine for the treatment of tau pathology

Phospho-tau–specific vaccine for the treatment of tau pathology

Novel phospho-tau-specific liposome-based vaccines to treat tau pathology

O4‐03‐04: Novel phospho‐tau‐specific liposome‐based vaccines to treat tau pathology

Novel phospho-Tau specific monoclonal antibodies for the treatment of Tau-mediated pathology

P3‐281: The safety profile of ACI‐24, an oligo‐specific amyloid beta vaccine, demonstrated decrease of large microbleedings in brain of aged Alzheimer's disease mouse model

The safety profile of ACI-24, an oligo-specific amyloid beta vaccine, demonstrated decrease of large microbleedings in brain of aged Alzheimer's disease mouse model

Efficacy and Safety of A Liposome-Based Vaccine against Protein Tau, Assessed in Tau.P301L Mice That Model Tauopathy. e72301

Cloning and overexpression of Lactobacillus helveticusd‐lactate dehydrogenase gene in Escherichia coli

Glutamate 264 modulates the pH dependence of the NAD(+)-dependent D-lactate dehydrogenase

Cloning and overexpression of Lactobacillus helveticus D-lactate dehydrogenase gene in Escherichia coli

Suchergebnisse filtern